These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10812116)

  • 1. Effects of hepatitis C virus infection on cyclosporine trough levels in renal transplant patients.
    Tuncer M; Süleymanlar G; Ersoy FF; Yakupoğlu G
    Transplant Proc; 2000 May; 32(3):569-71. PubMed ID: 10812116
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients.
    Manzanares C; Moreno M; Castellanos F; Cubas A; Herrero JC; Morales-Ruiz E; Segura J; Andres A; Morales JM
    Transplant Proc; 1998 Jun; 30(4):1264-5. PubMed ID: 9636513
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of antibody to hepatitis C virus in renal transplant recipients.
    Fernandez JA; Roth D; Burke G; Ranjan D; Esquenazi V; Miller J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):444-5. PubMed ID: 1846716
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C virus infection after renal transplantation: prevalence and course of morphologic lesions.
    Sandrini S; Chiappini R; Setti G; Carli O; Matricardi L; Puoti M; Callea F; Favret M; Maiorca R
    Transplant Proc; 1998 Aug; 30(5):2100-1. PubMed ID: 9723405
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine A: peak or trough level monitoring in renal transplant recipients?
    Wacke R; Drewelow B; Kundt G; Hehl EM; Bast R; Seiter H
    Transplant Proc; 2001; 33(7-8):3122-3. PubMed ID: 11750342
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine trough levels in renal graft recipients.
    Jauhari H; Wadhawan S; Yashpal ; Kumar A
    J Indian Med Assoc; 1999 Nov; 97(11):476-7. PubMed ID: 10638120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C antibody in renal transplant patients.
    Klauser R; Franz M; Traindl O; Pidlich J; Hay U; Watschinger B; Pohanka E; Kovarik J
    Transplant Proc; 1992 Feb; 24(1):286-8. PubMed ID: 1371619
    [No Abstract]   [Full Text] [Related]  

  • 8. A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levels.
    Mahalati K; Belitsky P; West K; Kiberd B; MacDonald A; McAlister V; Lawen J
    Transplant Proc; 2000 Jun; 32(4):786-7. PubMed ID: 10856585
    [No Abstract]   [Full Text] [Related]  

  • 9. Time-dependent difference of the 12-hour trough levels of cyclosporine in renal transplant recipients with sandimmune capsule.
    To H; Haba T; Uchida K; Fujimura A; Kobayashi E
    Transplant Proc; 2000 Feb; 32(1):221-2. PubMed ID: 10701028
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical implications of the presence of antibodies to hepatitis C after renal transplantation.
    Morales M; Campo C; Castellano G; Colina F; Andres A; Fuertes A; Praga M; Rodicio JL
    Transplant Proc; 1992 Feb; 24(1):78-80. PubMed ID: 1371627
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatitis C virus and renal transplant].
    Ibarra H; Mezzano S; Riegemann S; Toledo C; Ardiles L; Reinhardt G; Castillo A
    Rev Med Chil; 1992 Jan; 120(1):81-2. PubMed ID: 1284811
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of kidney functions and cyclosporine levels in renal transplant patients on Panimum Bioral in post transplant period.
    Sharma DR; Singh S
    J Indian Med Assoc; 1999 May; 97(5):204-5. PubMed ID: 10652891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of active infection on cytochrome P450-mediated metabolism of cyclosporine in renal transplant patients.
    Hegazy SK; Adam AG; Hamdy NA; Khalafallah NM
    Transpl Infect Dis; 2015 Jun; 17(3):350-60. PubMed ID: 25702620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine trough levels in diabetic and nondiabetic renal transplant patients.
    Wadhawan S; Jauhari H; Singh S
    Transplant Proc; 2000 Nov; 32(7):1683-4. PubMed ID: 11119891
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.
    Roos K; Gotthardt D; Giese T; Schnitzler P; Stremmel W; Czock D; Eisenbach C
    Liver Transpl; 2014 Sep; 20(9):1106-17. PubMed ID: 24890314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early achievement of target cyclosporine levels during initial post-transplant period with a novel dosing strategy.
    Chueh SC; Lai MK
    Transplant Proc; 1998 Aug; 30(5):1681-2. PubMed ID: 9723242
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of trough level and C(2) cyclosporine blood concentration monitoring in outpatient kidney transplant recipients.
    Braun F; Armstrong VW; Lorf T; Canelo R; Arndt C; Oellerich M; Ringe B
    Transplant Proc; 2001; 33(7-8):3108-9. PubMed ID: 11750336
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus infection in kidney transplant recipients.
    Valeri M; Pisani F; De Paolis P; Piazza A; Torlone N; Utzeri G; Elli M; Tisone G; Adorno D; Casciani CU
    Transplant Proc; 1993 Jun; 25(3):2284-5. PubMed ID: 7685948
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine trough level or 2-hour postdose level monitoring among kidney transplant recipients: Iranian practice.
    Einollahi B; Rostami Z; Teimoori M
    Iran J Kidney Dis; 2012 Sep; 6(5):389-90. PubMed ID: 22976267
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
    Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
    Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.